Hanmi Pharm Successfully Concludes Open Innovation Event with Kiwoom Securities

Over 80 Industry Experts Participate

Hanmi Pharm successfully hosted an open innovation event designed to connect bio ventures with investors.

Hanmi Pharm announced on the 16th that, together with Kiwoom Securities, it held the 'Hanmi x Kiwoom Bio Innovation Day' at Hanmi C&C Square in Songpa-gu, Seoul, the previous day.

Hanmi Pharmaceutical and Kiwoom Securities held the "Hanmi x Kiwoom Bio Innovation Day" on the 15th at Hanmi C&C Square in Songpa-gu, Seoul. Hanmi Pharmaceutical

The event featured IR presentations from 10 domestic bio ventures and offered one-on-one meetings between participating companies and investors. More than 80 key figures from the pharmaceutical and biotech industry—including promising domestic bio ventures, venture capital firms (VC), private equity funds (PE), securities companies, and strategic investors (SI)—attended, sharing innovative technologies and market potential while seeking tangible investment and business cooperation opportunities.

Hanmi Pharm plans to further develop this event into an open innovation platform in the pharmaceutical and biotech industry, continuously connecting promising bio ventures with investors.

Hanmi Pharm CEO Hwang Sangyeon stated, "The competitiveness of the bio industry is further strengthened when the creative ideas of bio ventures and academia are organically linked with the research and development (R&D) and commercialization capabilities of the pharmaceutical industry." He added, "I hope this event serves as a touchpoint of trust between companies and investors, building a foundation for collaboration and leading to follow-up discussions."

This content was produced with the assistance of AI translation services.